Evidence map›Paper›PMID 34363134›Full record

ArticleEuropean radiology2022

Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.

Sudhakar K Venkatesh, Christopher L Welle, Frank H Miller, Kartik Jhaveri, Kristina I Ringe, John E Eaton, Helen Bungay, Lionel Arrivé, Ahmed Ba-Ssalamah, Aristeidis Grigoriadis and 3 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Unmet needs in autoimmune liver diseases.Current opinion in immunology · 2025
    Review
  14. Endoscopic management of primary sclerosing cholangitis.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2025
    Review
  15. Review
  16. Review
  17. Primary sclerosing cholangitis.Nature reviews. Disease primers · 2025
    Review
  18. Article
  19. Pandemic COVID-19 as a challenge for telemedicine in the Czech Republic.The International journal of health planning and management · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 7 countries.

Sudhakar K VenkateshDivision of Abdominal Imaging, Department of Radiology, Mayo Clinic, 200, First Street SW, Rochester, MN, 55905, USA. Venkatesh.sudhakar@mayo.edu.ORCID http://orcid.org/0000-0002-7514-1030
Christopher L WelleDivision of Abdominal Imaging, Department of Radiology, Mayo Clinic, 200, First Street SW, Rochester, MN, 55905, USA.
Frank H MillerDepartment of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Kartik JhaveriJoint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada.
Kristina I RingeDepartment of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
John E EatonDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Helen BungayRadiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Lionel ArrivéDepartment of Radiology, Saint-Antoine Hospital, APHP Sorbonne University, Paris, France.
Ahmed Ba-SsalamahDepartment of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Aristeidis GrigoriadisDepartment of Abdominal Radiology, Karolinska University Hospital, Stockholm, Sweden.
Christoph Schramm1st Department of Medicine, Martin Zeitz Center for Rare Diseases, and Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ann S FulcherDepartment of Radiology, Virginia Commonwealth University, Richmond, VA, USA.
IPSCSG
Mayo Clinic · USKarolinska University Hospital · SEMayo Clinic in Arizona · USMedical University of Vienna · ATMedizinische Hochschule Hannover · DENorthwestern University · USOxford University Hospitals NHS Trust · GBSorbonne Université · FRUniversität Hamburg · DEUniversity Health Network · CAVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary sclerosing cholangitis (PSC) is a chronic inflammatory disorder affecting the bile ducts and is characterized by biliary strictures, progressive liver parenchymal fibrosis, and an increased risk of hepatobiliary malignancies primarily cholangiocarcinoma (CCA). PSC may lead to portal hypertension, liver decompensation, and liver failure with the need for liver transplantation. Magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) are considered the imaging standard for diagnosis and follow-up in patients with PSC. Currently, there are no universally accepted reporting standards and definitions for MRI/MRCP features. Controversies exist about the definition of a high-grade stricture and there is no widely agreed approach to their management. The members of the MRI working group of the International Primary Sclerosing Cholangitis Study Group (IPSCSG) sought to define terminologies and reporting standards for describing MRI/MRCP features that would be applied to diagnosis and surveillance of disease progression, and potentially for evaluating treatment response in clinical trials. In this extensive review, the technique of MRI/MRCP and assessment of image quality for the evaluation of PSC is briefly described. The definitions and terminologies for severity and length of strictures, duct wall thickening and hyperenhancement, and liver parenchyma signal intensity changes are outlined. As CCA is an important complication of PSC, standardized reporting criteria for CCA developing in PSC are summarized. Finally, the guidelines for reporting important changes in follow-up MRI/MRCP studies are provided. KEY POINTS: • Primary sclerosing cholangitis is a chronic inflammatory disorder affecting the bile ducts, causing biliary strictures and liver fibrosis and an increased risk of cholangiocarcinoma. • This consensus document provides definitions and suggested reporting standards for MRI and MRCP features of primary sclerosing cholangitis, which will allow for a standardized approach to diagnosis, assessment of disease severity, follow-up, and detection of complications. • Standardized definitions and reporting of MRI/MRCP features of PSC will facilitate comparison between studies, promote longitudinal assessment during management, reduce inter-reader variability, and enhance the quality of care and communication between health care providers.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaCholangitis, SclerosingBile Ducts, IntrahepaticCholangiopancreatography, Magnetic ResonanceHumansMagnetic Resonance ImagingBiliary stricturesCholangiocarcinomaDefinitionSclerosing cholangitisTerminology

Identifiers

PMID34363134
OpenAlexW3188651548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.